Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity

NCT02390531 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Retinopathy of Prematurity

Interventions

DRUG: Bevacizumab

Sponsor

Jaeb Center for Health Research

Collaborators

[object Object]
[object Object]